• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Electronic Prescribing Waiver Request

    Effective January 1, 2022, Senate Bill 0166 (CH0299)/House Bill 0512 (CH0230) Drugs and Devices – Electronic Prescriptions – Controlled Dangerous Substances requires licensed health care providers to electronically prescribe prescriptions for controlled dangerous substances. The Health General Article, 21-220(C) provides exceptions to this requirement, and the requirement to request a waiver. A health care practitioner who is unable to electronically transmit prescriptions for controlled dangerous substance drugs may request a waiver from the electronic prescribing requirement under certain circumstances. A waiver, if granted, may not exceed one year.

    To view existing electronic prescribing waiver recipients, visit the Online Waiver Verification page​.

    Electronic Prescribing Instructions & Application

     A. You can apply for a waiver under the following circumstances:

    • Economic Hardship.
    • Technological limitations that are not reasonably within the control of the health practitioner; or
    • Any other exceptional circumstances as demonstrated by the health practitioner.

    B. You are not required to obtain a waiver or prescribe electronically under the following exceptions:

    A Health Practitioner may issue a written, or if authorized by state and federal law, oral prescription for a controlled dangerous substance if:

    • Electronic prescribing is not available due to a temporary technological or electrical failure
    • The prescription is to be dispensed by a pharmacy located outside of the state
    • The prescribing entity and dispensing entity of the drug or device are the same
    • The prescription is issued by a health practitioner outside of the state
    • The health practitioner is prescribing and dispensing the controlled dangerous substance directly to the patient.
    • The prescription is being dispensed directly to the patient in accordance with §12-102(2)(IV) of the Health Occupations Article.
    • The prescription is for an individual who:
      • Resides in a nursing or assisted living facility; or
      • is receiving care through a hospice or palliative care program and the prescription is related to the care provided,
      • is receiving care at an outpatient renal dialysis facility and the prescription is related to the care provided
      • is incarcerated in a state detained or confined in a correctional facility as defined in§ 1-101 of the   Correction Services Article
    • The prescription is issued by a licensed veterinarian
    • The prescription includes elements that are not supported by the most recent version of the National Council for Prescription Drug Programs Prescriber/Pharmacist interface Script Standard
    • The prescription is issued for a drug for which the federal Food and Drug Administration requires the prescription to contain certain elements that cannot be transmitted electronically.
    • The prescription is not specific to one patient, including prescriptions that are:
      • in accordance with a standing order
      • for an approved protocol for drug therapy
      • for collaborative drug management
      • the comprehensive medication management, or
      • in response to a public health emergency
    • The prescription prescribes a drug under a research protocol.
    • The prescription is issued by a health practitioner who has received a waiver by the Maryland Department of Health.
    • The prescription is issued by a health practitioner who requested a waiver, and the Department has not issued the waiver to the practitioner or has not rejected the practitioners request for a waiver.
    • The health practitioner issuing the prescription or the drug for which the prescription is issued falls under a waiver issued by the Secretary.
    • The prescription is issued by a health practitioner who writes a low volume of prescriptions for controlled substances, as determined by the Maryland Health care Commission.
    • The health practitioner reasonably determines that it would be impactable for the practitioner to prescribe the drug or device by electronic means:
      • in a timely manner; and
      • the delay would adversely impact the patient's medical condition.



    All approved waivers will be public information and posted on the Office of Controlled Substance Administration website.

    Click here to complete and submit an Electronic Prescribing Waiver Request.